NCT02615015

Brief Summary

Neutrophil extracellular traps (NETs) and deoxyribonuclease (DNase) activity determine outcome in ST elevation acute coronary syndrome (STE-ACS). DNase single nucleotide polymorphisms (SNPs) were increased in a japanese cohort. In the present study, the investigators seek to measure DNase SNPs frequency in a caucasian STE-ACS cohort compared to healthy controls (each n=400). The investigators will compute polymorphisms, DNase activity, NET surrogate markers and clinical variables in regression models.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2015

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 25, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

March 23, 2017

Status Verified

March 1, 2017

Enrollment Period

3.3 years

First QC Date

November 12, 2015

Last Update Submit

March 21, 2017

Conditions

Keywords

Deoxyribonuclease

Outcome Measures

Primary Outcomes (1)

  • Frequency of SNPs of the DNase 1 and DNase gamma genes in the STE-ACS patient population compared to healthy controls

    through study completion, an average of 2 years

Secondary Outcomes (7)

  • Correlation of SNPs of the DNase 1 and gamma gene with DNase activity

    through study completion, an average of 2 years

  • Correlation of SNPs with major adverse cardiac events

    through study completion, an average of 2 years

  • Correlation of DNAse activity with major adverse cardiac events

    through study completion, an average of 2 years

  • Correlation of SNPs with DNA-Histone complex levels

    through study completion, an average of 2 years

  • Correlation of SNPs with MPO-DNA complex levels

    through study completion, an average of 2 years

  • +2 more secondary outcomes

Study Arms (2)

ST elevation myocardial infarction patient cohort

Patients who suffered from ST elevation myocardial infarction since 2006, referred to the General Hospital of Vienna and received primary percutaneous coronary intervention.

Other: Blood draw

Healthy proband cohort

Age matched healthy individuals who voluntarily participate in the study.

Other: Blood draw

Interventions

Healthy proband cohortST elevation myocardial infarction patient cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ST elevation myocardial infarction patients, who have been hospitalized in the General Hospital of Vienna since 2006 for ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention (pPCI) with TIMI 0-1.

You may qualify if:

  • Medical history
  • Detailed clinical examination
  • Electrocardiography
  • Echocardiography
  • Routine blood draw (differential blood count, clotting factors including fibrinogen, liver enzymes, creatine kinase (CK), CK-MB, C-reactive protein (CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), HbA1c
  • Blood draw for research experiments

You may not qualify if:

  • Patients under 18 years; auto-immune disease, immune-modulating medication, systemic infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (10)

  • Nichols M, Townsend N, Scarborough P, Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J. 2013 Oct;34(39):3017-27. doi: 10.1093/eurheartj/eht159. Epub 2013 Jun 25.

    PMID: 23801825BACKGROUND
  • Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21;352(16):1685-95. doi: 10.1056/NEJMra043430. No abstract available.

    PMID: 15843671BACKGROUND
  • Mangold A, Alias S, Scherz T, Hofbauer M, Jakowitsch J, Panzenbock A, Simon D, Laimer D, Bangert C, Kammerlander A, Mascherbauer J, Winter MP, Distelmaier K, Adlbrecht C, Preissner KT, Lang IM. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res. 2015 Mar 27;116(7):1182-92. doi: 10.1161/CIRCRESAHA.116.304944. Epub 2014 Dec 29.

    PMID: 25547404BACKGROUND
  • Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5. doi: 10.1073/pnas.1005743107. Epub 2010 Aug 23.

    PMID: 20798043BACKGROUND
  • Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Ten Cate H, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BLJH. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2032-2040. doi: 10.1161/ATVBAHA.113.301627. Epub 2013 Jul 1.

    PMID: 23818485BACKGROUND
  • Napirei M, Ludwig S, Mezrhab J, Klockl T, Mannherz HG. Murine serum nucleases--contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 2009 Feb;276(4):1059-73. doi: 10.1111/j.1742-4658.2008.06849.x. Epub 2009 Jan 16.

    PMID: 19154352BACKGROUND
  • Ueki M, Takeshita H, Fujihara J, Iida R, Yuasa I, Kato H, Panduro A, Nakajima T, Kominato Y, Yasuda T. Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme. Clin Chim Acta. 2009 Sep;407(1-2):20-4. doi: 10.1016/j.cca.2009.06.022. Epub 2009 Jun 24.

    PMID: 19559017BACKGROUND
  • Ueki M, Kimura-Kataoka K, Takeshita H, Fujihara J, Iida R, Sano R, Nakajima T, Kominato Y, Kawai Y, Yasuda T. Evaluation of all non-synonymous single nucleotide polymorphisms (SNPs) in the genes encoding human deoxyribonuclease I and I-like 3 as a functional SNP potentially implicated in autoimmunity. FEBS J. 2014 Jan;281(1):376-90. doi: 10.1111/febs.12608. Epub 2013 Dec 10.

    PMID: 24206041BACKGROUND
  • Kumamoto T, Kawai Y, Arakawa K, Morikawa N, Kuribara J, Tada H, Taniguchi K, Tatami R, Miyamori I, Kominato Y, Kishi K, Yasuda T. Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients. Eur Heart J. 2006 Sep;27(17):2081-7. doi: 10.1093/eurheartj/ehl177. Epub 2006 Jul 28.

    PMID: 16877481BACKGROUND
  • Crimi G, Pica S, Raineri C, Bramucci E, De Ferrari GM, Klersy C, Ferlini M, Marinoni B, Repetto A, Romeo M, Rosti V, Massa M, Raisaro A, Leonardi S, Rubartelli P, Oltrona Visconti L, Ferrario M. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc Interv. 2013 Oct;6(10):1055-63. doi: 10.1016/j.jcin.2013.05.011.

    PMID: 24156966BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood draw, DNA isolation, plasma isolation

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 12, 2015

First Posted

November 25, 2015

Study Start

September 1, 2015

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

March 23, 2017

Record last verified: 2017-03